Indian J Med Microbiol Close
 

Figure 1: (a) The prevalence of peroxisome proliferator-activated receptor-γ genotypes in cases and control participants. (b) The prevalence of peroxisome proliferator-activated receptor-γ alleles in cases and control participants. (c) Significant association between heteropolymorphism and nonobese cases. (d) Significant association between Ala allele and obese cases. (e) Significant association between heteropolymorphism and nonobese cases. (f) Significant association between Ala allele and nonobese cases

Figure 1: (a) The prevalence of peroxisome proliferator-activated receptor-γ genotypes in cases and control participants. (b) The prevalence of peroxisome proliferator-activated receptor-γ alleles in cases and control participants. (c) Significant association between heteropolymorphism and nonobese cases. (d) Significant association between Ala allele and obese cases. (e) Significant association between heteropolymorphism and nonobese cases. (f) Significant association between Ala allele and nonobese cases